ipamorelin research compound (RUO) | Selective GHS-R1a Agonist Ipamorelin 2mg-10mg Research Peptide |

Ongoing support from our pharmacy team throughout your peptide journey

Nutritional Information Nutritional Information Serving Size: 1 Capsule ***Daily Value not established

CJC-1295 and ipamorelin are commonly used together because they have complementary time-release characteristics: CJC-1295 is effectively GHRH that has been modified to have a longer half-life, so it stimulates pituitary growth hormone secretion in a sustained manner over an extended period.9 Ipamorelin acts on the pituitary gland directly, inducing a more immediate dump of growth hormone into circulation

In addition to the in vivo assay, the study also evaluated the pharmacological effects of the peptides on isolated guinea pig ileum tissue

Ongoing Supervision Regular follow-ups include lab testing (IGF-1, glucose, metabolic markers), clinical assessment of sleep, energy, body composition, and side effects